Clinical Trial Update: Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial investigating the effectiveness of tocilizumab for COVID-19 pneumonia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Biogipuzkoa Health Research Institute | Conditions: COVID-19 Pneumonia | Phase 3 | Status: UNKNOWN